KROS: Keros Therapeutics Inc
KROS exchange rate has changed by 1.89% for today. During the day, the instrument was traded at a low of 11.02 and at a high of 11.40.
Follow Keros Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KROS News
- Why Is Keros Therapeutics (KROS) Up 8% Since Last Earnings Report?
- KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak
- Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?
- KROS Q2 Earnings Miss as Revenues Fall to Zero, Pipeline in Focus
- New Strong Sell Stocks for July 30th
- Incyte (INCY) Q2 Earnings and Revenues Top Estimates
- Nurix Therapeutics (NRIX) Soars 16.4%: Is Further Upside Left in the Stock?
- Keros Therapeutics, Inc. (KROS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
- KROS Turns to Next Wave of TGF-Beta Muscle Therapies
- KROS Turns to Next Wave of TGF-Beta Muscle Therapies
- Should You Buy KROS After Q1 Miss and Takeda Deal Reset?
- Should You Buy KROS After Q1 Miss and Takeda Deal Reset?
- KROS Stock Guide to Rinvatercept in DMD and ALS for 2026
- KROS Stock Guide to Rinvatercept in DMD and ALS for 2026
- Keros Q1 Loss Wider Than Expected, Revenues Plunge Year Over Year
- Keros Therapeutics, Inc. (KROS) Reports Q1 Loss, Misses Revenue Estimates
- Aytu BioPharma, Inc. (AYTU) Reports Q3 Loss, Tops Revenue Estimates
- Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates
- KROS 2026 Watchlist: 3 Catalysts That Could Reset Sentiment
- KROS Stock: Does the Takeda Deal Lower Dilution Risk in 2026?
- KROS Rinvatercept: What to Know Before DMD Phase II Starts
- Why Is Keros Therapeutics (KROS) Up 2.5% Since Last Earnings Report?
- Insmed (INSM) Soars 5.5%: Is Further Upside Left in the Stock?
- KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026
Frequently Asked Questions
What is KROS stock price today?
Keros Therapeutics Inc stock is priced at 11.32 today. It trades within 11.02 - 11.40, yesterday's close was 11.11, and trading volume reached 174. The live price chart of KROS shows these updates.
Does Keros Therapeutics Inc stock pay dividends?
Keros Therapeutics Inc is currently valued at 11.32. Dividend policy depends on the company, while investors also watch -25.03% and USD. View the chart live to track KROS movements.
How to buy KROS stock?
You can buy Keros Therapeutics Inc shares at the current price of 11.32. Orders are usually placed near 11.32 or 11.62, while 174 and 2.63% show market activity. Follow KROS updates on the live chart today.
How to invest into KROS stock?
Investing in Keros Therapeutics Inc involves considering the yearly range 9.69 - 22.55 and current price 11.32. Many compare 2.72% and 2.17% before placing orders at 11.32 or 11.62. Explore the KROS price chart live with daily changes.
What are Keros Therapeutics Inc stock highest prices?
The highest price of Keros Therapeutics Inc in the past year was 22.55. Within 9.69 - 22.55, the stock fluctuated notably, and comparing with 11.11 helps spot resistance levels. Track Keros Therapeutics Inc performance using the live chart.
What are Keros Therapeutics Inc stock lowest prices?
The lowest price of Keros Therapeutics Inc (KROS) over the year was 9.69. Comparing it with the current 11.32 and 9.69 - 22.55 shows potential long-term entry points. Watch KROS moves on the chart live for more details.
When did KROS stock split?
Keros Therapeutics Inc has gone through stock splits historically. These changes are visible in , 11.11, and -25.03% after corporate actions.
- Previous Close
- 11.11
- Open
- 11.03
- Bid
- 11.32
- Ask
- 11.62
- Low
- 11.02
- High
- 11.40
- Volume
- 174
- Daily Change
- 1.89%
- Month Change
- 2.72%
- 6 Months Change
- 2.17%
- Year Change
- -25.03%